ACE-inhibitors versus angiotensin receptor blockers for renoprotection: conclusions from the evidence and from the evidence behind the evidence.
Van Biesen
W
W
Van Vlem
B
B
Schepkens
H
H
Lameire
N
N
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D051437:Renal Insufficiency / Q000188:drug therapy* / Q000517:prevention & control*; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors